Your session is about to expire
← Back to Search
ARFID-PTP for Avoidant/Restrictive Food Intake Disorder (ARFID-PTP Trial)
ARFID-PTP Trial Summary
This trial assesses if a two-session, virtual parent-training exposure protocol is effective for children ages 5-12 with picky eating.
- Avoidant/Restrictive Food Intake Disorder
- Avoidant Restrictive Food Intake Disorder
ARFID-PTP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ARFID-PTP Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the primary criterion for participation in this research initiative age or other factors?
"This medical trial wants to enrol patients that are between 5 and 12 years of age."
Are there still opportunities to join this trial?
"The trial, which was inaugurated on February 15th 2021 is still actively recruiting according to the statistics published on clinicaltrials.gov. The info has been most recently updated as of June 15th 2022."
Is there a way for me to get involved in this medical experiment?
"This research trial is seeking 40 young individuals aged 5 to 12 who have been diagnosed with avoidant restrictive food intake disorder. To be eligible, a child must meet the criteria established by the Pica, ARFID, Rumination Disorder Interview and they should not already be receiving medication or psychotherapy for their condition."
What is the primary aim of this medical experiment?
"This clinical trial's primary outcome is to measure the feasibility of recruitment, while secondary outcomes include assessing dietary regularity (number of foods in "regular rotation"), progress towards predetermined treatment goals, and parental perception of a child's eating behaviours via the Behavioral Pediatric Feeding Assessment Scale. All these metrics will be evaluated over an 2-week period post intervention."
How many test subjects are involved in this clinical experiment?
"Affirmative. Clinicaltrials.gov attests that the trial, which was initially posted on February 15th 2021, is presently looking for participants. Specifically, 40 individuals are required to join from 1 medical centre."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger